GlassScriptPhysician profile
Peter W Naylor
NPI 1730133091
$2,778.42
in general payments reported to CMS, 2019-2025
21 companies · $198 in 2025
The $198 reported for 2025 was more than what a typical Psychiatry provider received nationally (typical 2025 total: $176).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $680 · 2020: $152 · 2022: $645 · 2023: $888 · 2024: $216 · 2025: $198.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,302.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,301.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lundbeck LLC | $525.05 | 2019-2024 | Rexulti |
| Abbvie INC. | $465.85 | 2022-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $327.97 | 2019-2025 | Trintellix |
| Otsuka America Pharmaceutical, INC. | $232.49 | 2019-2025 | Rexulti |
| Janssen Pharmaceuticals, INC | $221.29 | 2019-2023 | Spravato |
| Supernus Pharmaceuticals, INC. | $170.02 | 2022-2023 | Qelbree |
| Axsome Therapeutics, INC. | $154.56 | 2022-2023 | Auvelity |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $143.44 | 2023-2024 | Caplyta |
| Vanda Pharmaceuticals INC. | $130.79 | 2022-2024 | Fanapt, Hetlioz |
| Corium, LLC | $90.97 | 2022-2023 | Azstarys |
| Shire North American Group INC | $79.24 | 2019 | |
| Allergan, INC. | $49.54 | 2020 | |
| Idorsia Pharmaceuticals US INC | $37.82 | 2024 | Quviviq |
| Alkermes, INC. | $34.61 | 2022-2025 | Lybalvi |
| Tris Pharma INC | $23.74 | 2023 | Dyanavel Xr |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Owp Pharmaceuticals, INC. | $18.15 | 2019 | |
| Sunovion Pharmaceuticals INC. | $16.90 | 2019 | |
| Jazz Pharmaceuticals INC. | $16.07 | 2020 | |
| Ironshore Pharmaceuticals INC. | $15.48 | 2019 | |
| Neuronetics, INC. | $12.42 | 2019 | |
| Bausch Health US, LLC | $12.02 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Naylor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.